Pulmonary actinomycosis in a patient with diffuse systemic sclerosis treated with infliximab.
Marie
I
I
Lahaxe
L
L
Levesque
H
H
Heliot
P
P
D000196:Actinomycosis / Q000139:chemically induced*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D000069285:Infliximab; D008171:Lung Diseases / Q000139:chemically induced*; D009894:Opportunistic Infections / Q000139:chemically induced*; D045743:Scleroderma, Diffuse / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab